Presumptive injection-site sarcoma in a white tiger (Panthera tigris tigris): A case report

PDF (English)
Δημοσιευμένα: Jan 18, 2024
Ενημερώθηκε: 2024-01-18
DOI: https://doi.org/10.12681/jhvms.30244
H Moosavian
Department of Clinical Pathology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
https://orcid.org/0000-0003-4785-1702
H Esmaeilzadeh
Department of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, Indiana, USA
M Fazli
Department of Biology, Faculty of Basic Science, Islamic Azad University, Tehran, Iran
CA Thompson
Department of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, Indiana, USA
A Farajzadeh
Doctor of Veterinary Medicine, Private Practice, Tehran, Iran
Περίληψη

A 6-year-old female White Tiger (Panthera Tigris Tigris) was presented with a history of a recurrent ulcerating mass on the right lumbar wall which initially, was removed by surgery one year before presentation.  Cytological and histological findings were consistent with a cutaneous injection site sarcomas. Immunohistochemistry results revealed that the neoplastic cells were strongly positive for vimentin and weakly positive for alpha-smooth muscle actin (SMA), but negative for Cytokeratin AE1/AE3, s100, and Desmin. Positive staining for vimentin and SMA is consistent with myofibroblast reactivity and reflects a continuous inflammatory response seen in feline injection-site sarcomas.  Feline injection-site sarcomas are the most serious adverse effect following injection of the vaccine or some other pharmaceutical substances and should be considered in the differential diagnosis of skin swelling in injection sites in the Felidae family. Limited data are available for these tumors in animals outside of domesticated cats. To the best of our knowledge, there exists no available published information on the injection-site sarcoma in tigers. Similar to domestic felids, this case highlights the importance of considerations and management options in vaccination schedules for the reduction of sarcoma risk in wild felids.

Λεπτομέρειες άρθρου
  • Ενότητα
  • Case Report
Creative Commons License

Αυτή η εργασία είναι αδειοδοτημένη υπό το CC Αναφορά Δημιουργού – Μη Εμπορική Χρήση 4.0.

Οι συγγραφείς των άρθρων που δημοσιεύονται στο περιοδικό διατηρούν τα δικαιώματα πνευματικής ιδιοκτησίας επί των άρθρων τους, δίνοντας στο περιοδικό το δικαίωμα της πρώτης δημοσίευσης.

Άρθρα που δημοσιεύονται στο περιοδικό διατίθενται με άδεια Creative Commons 4.0 Non Commercial και σύμφωνα με την άδεια μπορούν να χρησιμοποιούνται ελεύθερα, με αναφορά στο/στη συγγραφέα και στην πρώτη δημοσίευση για μη κερδοσκοπικούς σκοπούς.

Οι συγγραφείς μπορούν να καταθέσουν το άρθρο σε ιδρυματικό ή άλλο αποθετήριο ή/και να το δημοσιεύσουν σε άλλη έκδοση, με υποχρεωτική την αναφορά πρώτης δημοσίευσης στο J Hellenic Vet Med Soc

Οι συγγραφείς ενθαρρύνονται να καταθέσουν σε αποθετήριο ή να δημοσιεύσουν την εργασία τους στο διαδίκτυο πριν ή κατά τη διαδικασία υποβολής και αξιολόγησής της.

Λήψεις
Τα δεδομένα λήψης δεν είναι ακόμη διαθέσιμα.
Αναφορές
Carneiro, C. S., G. F. de Queiroz, A. C. Pinto, M. L. Dagli and J. M.
Matera (2019). Feline injection site sarcoma: immunohistochemical
characteristics. J Feline Med Surg 21(4): 314-321.
Chang, H. W., S. Y. Ho, H. F. Lo, Y. C. Tu, C. R. Jeng, C. H. Liu, F. I.
Wang and V. F. Pang (2006). Vaccine-associated rhabdomyosarcoma
with spinal epidural invasion and pulmonary metastasis in a cat. Vet
Pathol 43(1): 55-58.
Couto, S. S., S. M. Griffey, P. C. Duarte and B. R. Madewell (2002). Feline vaccine-associated fibrosarcoma: morphologic distinctions. Vet
Pathol 39(1): 33-41.
Doddy, F. D., L. T. Glickman, N. W. Glickman and E. B. Janovitz (1996).
Feline fibrosarcomas at vaccination sites and non-vaccination sites.
Journal of Comparative Pathology 114(2): 165-174.
Eikelberg, D. J., L. Allnoch, P. Grothmann, J. Bohner and M. Hewicker‐Trautwein (2020). Subcutaneous fibrosarcomas with pulmonary
metastases in a white tiger (Panthera tigris) and a lion (Panthera leo).
Veterinary Record Case Reports 8(2): e000960.
Hendrick, M. (2000). Feline fibrosarcoma: vaccine associated. KIRKS
CURRENT VETERINARY THERAPY 13: 498-499.
Hendrick, M. J. (1998). Historical review and current knowledge of risk
factors involved in feline vaccine-associated sarcomas. J Am Vet Med
Assoc 213(10): 1422-1423.
Hendrick, M. J. and J. J. Brooks (1994). Postvaccinal sarcomas in the
cat: histology and immunohistochemistry. Vet Pathol 31(1): 126-129.
Kang, S., T. Southard and K. R. Hume (2017). DNA damage is a feature of
feline injection-site sarcoma. Vet Comp Oncol 15(2): 518-524.
Kass, P. H., W. G. Barnes, Jr., W. L. Spangler, B. B. Chomel and M. R.
Culbertson (1993). Epidemiologic evidence for a causal relation between vaccination and fibrosarcoma tumorigenesis in cats. J Am Vet
Med Assoc 203(3): 396-405.
Kinne, J. and W. Tarello (2007). Vaccine-associated fibrosarcoma in a lion
(Panthera leo). Revue de médecine vétérinaire 158(2): 73-74.
Martano, M., E. Morello and P. Buracco (2011). Feline injection-site sarcoma: past, present and future perspectives. Vet J 188(2): 136-141.
Munday, J. S., N. L. Stedman and L. J. Richey (2003). Histology and immunohistochemistry of seven ferret vaccination-site fibrosarcomas.
Vet Pathol 40(3): 288-293.
Porcellato, I., L. Menchetti, C. Brachelente, M. Sforna, A. Reginato, E.
Lepri and L. Mechelli (2017). Feline Injection-Site Sarcoma. Vet
Pathol 54(2): 204-211.
Powers, B. E., P. J. Hoopes and E. J. Ehrhart (1995). Tumor diagnosis,
grading, and staging. Semin Vet Med Surg (Small Anim) 10(3): 158-
Scherk, M. A., R. B. Ford, R. M. Gaskell, K. Hartmann, K. F. Hurley, M.
R. Lappin, J. K. Levy, S. E. Little, S. K. Nordone and A. H. Sparkes
(2013). 2013 AAFP Feline Vaccination Advisory Panel Report. J Feline Med Surg 15(9): 785-808.
Zabielska-Koczywąs, K., A. Wojtalewicz and R. Lechowski (2017). Current knowledge on feline injection-site sarcoma treatment. Acta Vet Scand 59(1): 47